Tyne Jeffrey is Chief Business Officer and Cofounder of PharmaPhixx, where she leads commercial strategy, sales, and client partnerships for engineering support in pharmaceutical manufacturing.

With over 20 years of experience in biotech sales and business development, she brings deep expertise in aseptic fill-finish and sterile processes.

Prior to PharmaPhixx, Tyne led sales at Berkshire Sterile Manufacturing, playing a key role in its growth and acquisition, and held leadership roles at Pall Corporation, Althea (now Aji Bio), and Hyaluron (now Curia). She holds a B.S. in Biology from Salve Regina University and an MBA certificate from UMass Dartmouth.